EMD-29641
YES Complex - E. coli MraY, Protein E ID21, E. coli SlyD
EMD-29641
Single-particle3.4 Å

Map released: 26/07/2023
Last modified: 19/06/2024
Sample Organism:
Escherichia coli K-12,
Escherichia phage ID21
Sample: YES complex
Fitted models: 8g01 (Avg. Q-score: 0.338)
Deposition Authors: Orta AK
,
Clemons WM,
Riera N
Sample: YES complex
Fitted models: 8g01 (Avg. Q-score: 0.338)
Deposition Authors: Orta AK


The mechanism of the phage-encoded protein antibiotic from Phi X174.
Orta AK
,
Riera N
,
Li YE
,
Tanaka S,
Yun HG,
Klaic L,
Clemons Jr WM
(2023) Science , 381 , eadg9091 - eadg9091




(2023) Science , 381 , eadg9091 - eadg9091
Abstract:
The historically important phage ΦX174 kills its host bacteria by encoding a 91-residue protein antibiotic called protein E. Using single-particle electron cryo-microscopy, we demonstrate that protein E bridges two bacterial proteins to form the transmembrane YES complex [MraY, protein E, sensitivity to lysis D (SlyD)]. Protein E inhibits peptidoglycan biosynthesis by obstructing the MraY active site leading to loss of lipid I production. We experimentally validate this result for two different viral species, providing a clear model for bacterial lysis and unifying previous experimental data. Additionally, we characterize the Escherichia coli MraY structure-revealing features of this essential enzyme-and the structure of the chaperone SlyD bound to a protein. Our structures provide insights into the mechanism of phage-mediated lysis and for structure-based design of phage therapeutics.
The historically important phage ΦX174 kills its host bacteria by encoding a 91-residue protein antibiotic called protein E. Using single-particle electron cryo-microscopy, we demonstrate that protein E bridges two bacterial proteins to form the transmembrane YES complex [MraY, protein E, sensitivity to lysis D (SlyD)]. Protein E inhibits peptidoglycan biosynthesis by obstructing the MraY active site leading to loss of lipid I production. We experimentally validate this result for two different viral species, providing a clear model for bacterial lysis and unifying previous experimental data. Additionally, we characterize the Escherichia coli MraY structure-revealing features of this essential enzyme-and the structure of the chaperone SlyD bound to a protein. Our structures provide insights into the mechanism of phage-mediated lysis and for structure-based design of phage therapeutics.